31,104 Shares in BWX Technologies, Inc. $BWXT Acquired by Insight Wealth Strategies LLC

Key Points

• Insight Wealth Strategies acquired 31,104 BWX Technologies shares worth approximately $5.95 million. Institutional investors and hedge funds collectively own 94.39% of the company.
• BWXT reported quarterly EPS of $1.07, exceeding the $1.04 consensus estimate, while revenue rose 18% year over year to $901.62 million. The company maintained fiscal 2026 EPS guidance of $4.70–$4.80.
• BWXT announced a quarterly dividend of $0.27, representing an annualized payout of $1.08 and a 0.6% yield. Analysts give the stock a “Moderate Buy” consensus rating with an average price target of $228.20, despite shares recently trading near $169.99.

Insight Wealth Strategies LLC acquired a new position in shares of BWX Technologies, Inc. (NYSE:BWXT - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 31,104 shares of the technology company's stock, valued at approximately $5,949,000.

Several other hedge funds and other institutional investors have also made changes to their positions in BWXT. Cannell & Spears LLC increased its stake in shares of BWX Technologies by 4.0% during the 1st quarter. Cannell & Spears LLC now owns 1,312 shares of the technology company's stock worth $251,000 after purchasing an additional 50 shares in the last quarter. Wedbush Securities Inc. lifted its position in shares of BWX Technologies by 4.3% in the fourth quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company's stock valued at $218,000 after acquiring an additional 52 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of BWX Technologies by 1.0% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 5,448 shares of the technology company's stock valued at $942,000 after acquiring an additional 54 shares during the last quarter. Guggenheim Capital LLC increased its position in BWX Technologies by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 2,598 shares of the technology company's stock worth $449,000 after purchasing an additional 55 shares in the last quarter. Finally, Private Advisor Group LLC grew its holdings in shares of BWX Technologies by 2.4% during the first quarter. Private Advisor Group LLC now owns 2,847 shares of the technology company's stock worth $582,000 after buying an additional 67 shares in the last quarter. Institutional investors and hedge funds own 94.39% of the company's stock.

BWX Technologies Trading Up 0.7%

BWXT stock opened at $169.99 on Wednesday. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.51. The company has a market cap of $15.57 billion, a price-to-earnings ratio of 44.04, a PEG ratio of 2.64 and a beta of 0.76. The business has a fifty day simple moving average of $184.32 and a 200-day simple moving average of $199.75. BWX Technologies, Inc. has a 52 week low of $157.10 and a 52 week high of $241.82.

BWX Technologies (NYSE:BWXT - Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.03. The firm had revenue of $901.62 million during the quarter, compared to the consensus estimate of $902.41 million. BWX Technologies had a return on equity of 30.83% and a net margin of 10.11%.The firm's quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.02 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. On average, equities research analysts expect that BWX Technologies, Inc. will post 4.75 EPS for the current year.

BWX Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, August 18th. BWX Technologies's dividend payout ratio is 27.98%.

Analysts Set New Price Targets

Several research firms have commented on BWXT. Zacks Research cut shares of BWX Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft upgraded BWX Technologies from a "hold" rating to a "buy" rating and raised their price objective for the stock from $205.00 to $255.00 in a report on Friday, May 15th. Weiss Ratings lowered BWX Technologies from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Wednesday, July 29th. Wall Street Zen lowered BWX Technologies from a "buy" rating to a "hold" rating in a research note on Saturday. Finally, BTIG Research restated a "buy" rating and issued a $235.00 price target on shares of BWX Technologies in a report on Tuesday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $228.20.

BWX Technologies Company Profile

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source